MACC1 and esophageal squamous cell carcinoma: Therefore, we infer that inhibiting the expression of both MACC1 and c-Met protein simultaneously is beneficial to prolong the overall survival of ESCC and that MACC1 and c-Met protein can be used as molecular markers for poor prognosis of ESCC.